Cathie's Ark Logo
Pacific Biosciences of California Inc Logo

ARKK Holdings of Pacific Biosciences (PACB) - Updated Daily

Genetic SequencingLab Equipment
Date
Direction
Shares
Fund Weight
Fund
December 14, 2022
SELL27.394k0.0038%ARKK
December 9, 2022
SELL224.167k0.0309%ARKK
August 22, 2022
BUY296.053k0.0202%ARKK
August 17, 2022
BUY177.784k0.0138%ARKK
August 16, 2022
BUY90.803k0.0666%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
1.85%$2.48b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
20🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
19$19.84
🎫ARK Ownership Percent
5.83%
Description
Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.
Website
www.pacb.com

Other ETFs That Hold PACB

Ticker
NameWeight
ARKGARK Genomic Revolution ETF5.31%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
ARKKARK Innovation ETF1.78%

Research Notes and Commentary for PACB